Weil Company’s Pfizer PFE Stock Holding History

Weil Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,308	Closed	-$231K	–	143
2023 Q2	$231K	Sell	6,308 -21	-0.3%	-$817	0.1%	128
2023 Q1	$258K	Hold	6,329	–	–	0.12%	117
2022 Q4	$324K	Hold	6,329	–	–	0.15%	101
2022 Q3	$277K	Hold	6,329	–	–	0.17%	102
2022 Q2	$332K	Hold	6,329	–	–	0.19%	93
2022 Q1	$328K	Hold	6,329	–	–	0.16%	105
2021 Q4	$374K	Hold	6,329	–	–	0.17%	96
2021 Q3	$272K	Hold	6,329	–	–	0.14%	115
2021 Q2	$248K	Sell	6,329 -155	-2%	-$6.03K	0.13%	125
2021 Q1	$235K	Buy	6,484 +300	+5%	+$10.7K	0.13%	132
2020 Q4	$228K	Sell	6,184 -334	-5%	-$12.3K	0.14%	121
2020 Q3	$227K	Sell	6,518 -158	-2%	-$5.54K	0.17%	95
2020 Q2	$207K	Hold	6,676	–	–	0.17%	88
2020 Q1	$207K	Sell	6,676 -620	-8%	-$21.1K	0.19%	81
2019 Q4	$271K	Buy	7,296 +335	+5%	+$11.9K	0.21%	86
2019 Q3	$237K	Buy	6,961 +106	+2%	+$3.85K	0.18%	84
2019 Q2	$282K	Buy	6,855 +158	+2%	+$6.27K	0.23%	84
2019 Q1	$270K	Hold	6,697	–	–	0.23%	84
2018 Q4	$277K	Hold	6,697	–	–	0.25%	76
2018 Q3	$280K	Buy	6,697 +27	+0.4%	+$1.04K	0.23%	80
2018 Q2	$230K	Buy	+6,670	New	+$228K	0.19%	87

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weil Company's PFE Position: Q3 2023 in Review

Weil Company sold out of Pfizer (PFE) in Q3 2023, closing a stake of 6,308 shares — an estimated $231K sold.

Weil Company first reported a position in PFE in Q2 2018 and held it in 21 quarters. The position peaked at $374K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Weil Company reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Weil Company sold 6,308 Pfizer shares in Q3 2023, an estimated $231K.
Weil Company first reported a position in Pfizer in Q2 2018 and held it in 21 quarters.
Weil Company's Pfizer position peaked at $374K in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Weil Company's 13F filing for Q3 2023, filed 8 Nov 2023.